Resuscitation of Severe Sepsis

Question: Does early resuscitation therapy designed to improve the oxygen supply/demand balance improve outcome in sepsis?
Yes; Grade B No; Grade B
Recommendations:
The resuscitation of a patient in severe sepsis or sepsis-induced tissue hypoperfusion (hypotension or lactate acidosis) should begin as soon as the syndrome is recognized and should not be delayed pending intensive care unit admission. An elevated serum lactate level identifies tissue hypoperfusion in patients at risk who are not hypotensive. During the first 6 hrs of resuscitation, the goals of initial resuscitation of sepsisinduced hypoperfusion should include all of the following as one part of a treatment protocol: central venous pressure of 8 -12 mm Hg, mean arterial pressure of Ն65 mm Hg, urine output of Ն0.5 mL·kg Ϫ1 ·hr Ϫ1 , and central venous (superior vena cava) (ScvO 2 ) or mixed venous oxygen (SvO 2 ) saturation of Ն70%.
Grade B
During the first 6 hrs of resuscitation of severe sepsis or septic shock, if ScvO 2 of 70% or SvO 2 of 65% is not achieved with fluid resuscitation to a central venous pressure of 8 -12 mm Hg, then transfuse packed red blood cells to achieve a hematocrit of Ն30% or administer a dobutamine infusion (up to a maximum of 20 g·kg Ϫ1 ·min Ϫ1 ) to achieve this goal.
A strategy of increasing cardiac index to achieve an arbitrarily predefined elevated level is not recommended. tolic blood pressure of Ͻ90 mm Hg after a 20 -30 mL/kg crystalloid challenge or a blood lactate concentration of Ͼ4 mmol/L. The patients were randomized to receive 6 hrs of standard therapy or 6 hrs of early goal-directed therapy before admission to the intensive care unit. Clinicians who were subsequently involved in the care of these patients were blinded to the treatment arm of the study.
The control group's care was directed according to a protocol for hemodynamic support. The aims of this protocol were to ensure that the patients had a central venous pressure of between 8 and 12 mm Hg, a mean arterial pressure of Ͼ65 mm Hg, and a urine output of Ͼ0.5 mL·kg Ϫ1 ·min Ϫ1 . These goals were targeted with the use of 500-mL boluses of crystalloid or colloid and then vasopressor agents as necessary. The patients assigned to the early goal-directed therapy group received a central venous catheter capable of measuring ScvO 2 . Their treatment aims were then the same as the control groups, except that they also had to achieve a ScvO 2 of Ͼ70%. This was achieved first by the administration of transfused red blood cells, then with positive inotropic therapy, and if this goal was then not achieved, by sedation and mechanical ventilation to reduce oxygen demand.
The study enrolled 263 patients equally between the two groups. There were no significant differences between the two groups at baseline. During the initial 6 hrs of therapy, the early goaldirected therapy group received more intravenous fluid (5.0 vs. 3.5 L, p Ͻ .001), red cell transfusions (p Ͻ .001), and inotropic therapy (p Ͻ .001). During the subsequent 66 hrs, the control group received more red cell transfusions (p Ͻ .001), more vasopressors (p ϭ .03), and had a greater requirement for mechanical ventilation (p Ͻ .001) and pulmonary artery catheterization (p ϭ .04). This in part reflects the fact that the control group patients were relatively underresuscitated initially, and this was noticed and thus acted on by clinicians later on in their treatment course. In-hospital mortality was significantly higher in the control group than in the early goal-directed therapy group (46.5% vs. 30.5%, p ϭ .009). These differences were maintained through to 28 (p ϭ .01) and 60 days (p ϭ .03).
The only study that demonstrates outcome improvement from early goaldirected resuscitation utilized ScvO 2 as one of the main end points (2). It is impossible to determine from the study which particular facet of the protocol was beneficial for the patients, so the protocol as a whole must be recommended. It does seem likely that the measurement of ScvO 2 as a surrogate of the oxygen supply/ demand balance was a vital part of this protocol and, as such, seems to be necessary in the resuscitation of these patients. It is not clear whether this end point should be followed on a continuous basis with the use of specialized central venous catheters or if the same effect could be achieved with intermittent sampling and measuring of central venous blood. The important point is that the central venous saturations are recognized to be important targets in this patient population.
In some clinical situations, these patients will be monitored with the use of pulmonary artery catheters and will have measurements of the SvO 2 . It seems intuitive that the SvO 2 should replace the ScvO 2 in these circumstances. It is not at all clear, however, how these two different variables equate to one another in patients with early sepsis. Several studies (3) (4) (5) (6) have demonstrated the SvO 2 to be lower than the ScvO 2 in the shock state. These studies, however, included only patients with hypovolemic, cardiogenic, and late septic shock. A recent study in critically ill patients (including septic shock patients) would support a 65% SvO 2 saturation as similar to a 70% ScvO 2 (7) .
Sepsis is associated with an increased oxygen demand, abnormalities in oxygen extraction, and myocardial depression. These abnormalities often persist despite a seemingly adequate cardiac index and may contribute to the high morbidity and mortality attached with this condition. There is some rationale, therefore, in increasing the cardiac index and therefore oxygen delivery to supranormal levels to overcome these abnormalities and potentially reduce complications and increase survival.
There are a number of studies addressing this issue, and the results remain contentious. Early studies from Shoemaker et al. (8) supported this approach and suggested that the cardiac index needed to be Ͼ4.5 L·min Ϫ1 ·m Ϫ2 , the oxygen delivery Ͼ600 mL·min Ϫ1 ·m Ϫ2 , and the oxygen consumption Ͼ170 mL·min Ϫ1 ·m Ϫ2 . Utilizing these values as goals or end points of resuscitation, the researchers were able to significantly reduce mortality. This work was performed in surgical patients, however, the majority of whom were not septic. Further studies in heterogeneous groups of critically ill patients have not been so clear cut (2, 9 -11) . Tuchschmidt et al. (9) reported the results of a small study of patients in septic shock. They received either 72 hrs of standard therapy or 72 hrs of therapy designed to provide a "supranormal" cardiac index. There were no overall differences in outcome between the two groups. Similar findings were found by Gattinoni et al (10) . Hayes et al. (11) randomized a total of 109 critically ill patients to either standard therapy or the type of goals in Shoemaker et al. (8) and found an increased mortality in the protocol group. Yu et al. (2) studied patients with severe sepsis or septic shock who were unable to reach the end points of Shoemaker et al. (8) with fluid resuscitation alone. Importantly, they also specified that the study had to be started within 24 hrs of the diagnosis of sepsis being made. They demonstrated a decreased mortality rate in patients treated with the hyperdynamic approach so long as they were Ͻ75 yrs of age.
The strategy of routinely augmenting cardiac index and oxygen delivery to patients in established sepsis/septic shock with evidence of established organ dysfunction cannot be advocated. A generalized protocol that provides global end points that are not patient specific does not seem to be advantageous. This may be because what is beneficial to some patients may be harmful to others, thus giving an overall negative result. The one study that has attempted this approach early on in the intensive care unit course, by Yu et al. (2) , demonstrated reductions in mortality.
CONCLUSIONS
The successful resuscitation of patients in septic shock remains a challenging exercise. There are few studies that we have to base our decision making process on. There are a few points that we can learn from the literature however that are both salient and important. The first and probably most important point is that the resuscitation must start early. It seems that the longer the resuscitation is delayed, the less likely a beneficial effect will be accrued. This makes sense, as the purpose of resuscitating a patient is to prevent further organ dysfunction and failure. If the resuscitation is delayed until after cellular dysfunction and death is present, then strategies designed to pro-vide the cells with more oxygen are unlikely to be helpful. It is unclear however when the transition from reversible cellular dysfunction to irreversible cellular dysfunction occurs. At present, the only strategy that we can employ is to provide the resuscitation at the earliest stage possible. The second point is that the protocols used to resuscitate the patients must in some way be patient specific. Global end points that do not account for the body's metabolic status do not seem to be useful in this patient setting. Using markers of the metabolic status such as the central venous oxygen tension can lead to positive effects in terms of survival.
